Colistin
5
0
0
3
Key Insights
Highlights
Success Rate
75% trial completion
Treatment Research
4 treatments under study, led by Colistimethate Sodium
Research Leaders
12 sponsors active, led by Directorate of Veterinary Public Health, Ministry of Agriculture
Related Conditions
Often studied with 9 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
20.0%
1 terminated out of 5 trials
75.0%
-11.6% vs benchmark
40%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (5)
Pharmacokinetics of Colistin in Critically Ill Patients With Extracorporeal Membrane Oxygenation
Impact of Reducing Colistin Use on Colistin Resistance in Humans and Poultry in Indonesia
Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections
Evaluation of Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium
Colistin-rifampin Combination and Colistin Monotherapy in Extensively Drug-resistant Acinetobacter Baumannii
Research Network
Common Treatments
- Colistimethate Sodium2
- Colistin And Rifampin Combination Therapy1
- Colistin1
- Screening1
Active Sponsors
- Directorate of Veterinary Public Health, Ministry of Agriculture1
- Center For Indonesian Veterinary Analytical Studies1
- Erasmus Medical Center1
- Gangnam Severance Hospital1
- National Cancer Institute, Egypt1
Top Investigators
St. Anne's University Hospital Brno, Czech Republic
University of Colorado, Denver
Universitas Indonesia
National Cancer Institute, Egypt
Related Conditions
- Rifampin1
- Antimicrobial Resistance1
- Colonization Asymptomatic1
- Acinetobacter Infections1
- Colistin Adverse Reaction1